ATNM
Price
$1.44
Change
+$0.01 (+0.70%)
Updated
Jul 3 closing price
Capitalization
44.92M
22 days until earnings call
GBIO
Price
$0.34
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
22.99M
31 days until earnings call
Interact to see
Advertisement

ATNM vs GBIO

Header iconATNM vs GBIO Comparison
Open Charts ATNM vs GBIOBanner chart's image
Actinium Pharmaceuticals
Price$1.44
Change+$0.01 (+0.70%)
Volume$118.73K
Capitalization44.92M
Generation Bio
Price$0.34
Change-$0.00 (-0.00%)
Volume$676.58K
Capitalization22.99M
ATNM vs GBIO Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. GBIO commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and GBIO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ATNM: $1.44 vs. GBIO: $0.34)
Brand notoriety: ATNM and GBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 32% vs. GBIO: 89%
Market capitalization -- ATNM: $44.92M vs. GBIO: $22.99M
ATNM [@Biotechnology] is valued at $44.92M. GBIO’s [@Biotechnology] market capitalization is $22.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileGBIO’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • GBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, ATNM is a better buy in the long-term than GBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 4 TA indicator(s) are bullish while GBIO’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 4 bullish, 7 bearish.
  • GBIO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -11.11% price change this week, while GBIO (@Biotechnology) price change was -3.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

GBIO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($44.9M) has a higher market cap than GBIO($23M). ATNM YTD gains are higher at: 14.286 vs. GBIO (-67.642). ATNM has higher annual earnings (EBITDA): -48.36M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. ATNM (65.3M). ATNM has less debt than GBIO: ATNM (1.43M) vs GBIO (87.6M). GBIO has higher revenues than ATNM: GBIO (24.6M) vs ATNM (0).
ATNMGBIOATNM / GBIO
Capitalization44.9M23M195%
EBITDA-48.36M-69.2M70%
Gain YTD14.286-67.642-21%
P/E RatioN/AN/A-
Revenue024.6M-
Total Cash65.3M158M41%
Total Debt1.43M87.6M2%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
73
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMGBIO
RSI
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
88%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
80%
Aroon
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OGI1.430.05
+3.62%
Organigram Global Inc
CALC1.610.03
+1.90%
CalciMedica
MAIN61.130.97
+1.61%
Main Street Capital Corp
GHRS14.91-0.11
-0.77%
GH Research PLC
CNC33.31-0.47
-1.39%
Centene Corp

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with GBIO. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+0.70%
GBIO - ATNM
47%
Loosely correlated
+1.51%
IMNM - ATNM
36%
Loosely correlated
+2.43%
GLSI - ATNM
36%
Loosely correlated
+1.52%
HOWL - ATNM
36%
Loosely correlated
N/A
PRLD - ATNM
35%
Loosely correlated
-0.76%
More

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
+1.51%
CCCC - GBIO
50%
Loosely correlated
-2.63%
ABOS - GBIO
49%
Loosely correlated
+2.65%
IDYA - GBIO
49%
Loosely correlated
+0.82%
ATXS - GBIO
48%
Loosely correlated
+1.40%
FHTX - GBIO
48%
Loosely correlated
+3.64%
More